Mineral oil

Mineral oil Reactions 1704, p249 - 2 Jun 2018 Various toxicities: 12 case reports In a study, 12 men aged 24 50 years were described, who developed hypercalcaemia, hypercalciuria and renal impairment following administration of mineral oil [paraffin oil] for increasing apparent muscle size. In one out of these 12 men, paraffinomas was also noted. The men received IM injection of mineral oil for increasing apparent muscle size. Of these 12 men, seven men received IM injection of mineral oil in the dose range of 100 2000mL [not all dosages stated]. After 1 8 years from injection, they were admitted to the hospitals with hypercalcaemia, hypercalciuria and renal impairment. One of these 12 men also developed paraffinomas. The men received treatment with glucocorticoids, denosumab, zoledronic acid, pamidronic acid, calcitonin [Miacalcic], azathioprine, hydroxychloroquine [Plaquinil], mycophenolate or infliximab. One out of these 12 men underwent surgery in October 2016 for removal of the paraffinomas and the paraffinomas was surgically removed. Of these 12 men, the outcome of hypercalcaemia was reported as recovered (1 patient), recovering (4 patients), not recovered (3 patients) and unknown (4 patients) [not all outcomes stated]. Author comment: "We now report a case series of 12 patients with non-parathyroid hypercalcemia associated with intramuscular injections of paraffin oil." "In a few case reports, long-term side effects have been reported in terms of hypercalcemia and renal failure." Solling ASK, et al. Non-parathyroid hypercalcemia associated with paraffin oil injection in 12 younger male bodybuilders: a case series. European Journal of Endocrinology 178: K29-K37, No. 6, Jun 2018. Available from: URL: http:// doi.org/10.1530/EJE-18-0051 - Denmark 803322811 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Mineral oil

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/mineral-oil-06PdGRwCPy
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46892-z
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p249 - 2 Jun 2018 Various toxicities: 12 case reports In a study, 12 men aged 24 50 years were described, who developed hypercalcaemia, hypercalciuria and renal impairment following administration of mineral oil [paraffin oil] for increasing apparent muscle size. In one out of these 12 men, paraffinomas was also noted. The men received IM injection of mineral oil for increasing apparent muscle size. Of these 12 men, seven men received IM injection of mineral oil in the dose range of 100 2000mL [not all dosages stated]. After 1 8 years from injection, they were admitted to the hospitals with hypercalcaemia, hypercalciuria and renal impairment. One of these 12 men also developed paraffinomas. The men received treatment with glucocorticoids, denosumab, zoledronic acid, pamidronic acid, calcitonin [Miacalcic], azathioprine, hydroxychloroquine [Plaquinil], mycophenolate or infliximab. One out of these 12 men underwent surgery in October 2016 for removal of the paraffinomas and the paraffinomas was surgically removed. Of these 12 men, the outcome of hypercalcaemia was reported as recovered (1 patient), recovering (4 patients), not recovered (3 patients) and unknown (4 patients) [not all outcomes stated]. Author comment: "We now report a case series of 12 patients with non-parathyroid hypercalcemia associated with intramuscular injections of paraffin oil." "In a few case reports, long-term side effects have been reported in terms of hypercalcemia and renal failure." Solling ASK, et al. Non-parathyroid hypercalcemia associated with paraffin oil injection in 12 younger male bodybuilders: a case series. European Journal of Endocrinology 178: K29-K37, No. 6, Jun 2018. Available from: URL: http:// doi.org/10.1530/EJE-18-0051 - Denmark 803322811 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off